OMEGA STRATEGIES LLC (DC)

Lobbying for ON DEMAND PHARMACEUTICALS · Pharmaceutical Supply

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Income

$10,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 4

HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S 2296
National Defense Authorization Act for Fiscal Year 2026
HR 4016
Department of Defense Appropriations Act, 2026
S 2572
Department of Defense Appropriations Act, 2026

Lobbying activity 2

Pharmacy

National Defense Authorization Act, H.R. 3838, S. 2296, support for funding of the office of naval research for pharmaceutical and API production.

Budget/Appropriations

Defense Appropriatiations, H.R. 4016, S. 2572, support for funding of the office of naval research for pharmaceutical and API production.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.